This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Mar;5(2):87-8.

doi: 10.1007/s11912-003-0094-7.

Pegylated interferon alfa-2b as treatment of patients with solid tumors

Ronald M Bukowski

PMID: 12583824
DOI: 10.1007/s11912-003-0094-7

Comment

Pegylated interferon alfa-2b as treatment of patients with solid tumors

Ronald M Bukowski. Curr Oncol Rep. 2003 Mar.

. 2003 Mar;5(2):87-8.

doi: 10.1007/s11912-003-0094-7.

Author

Ronald M Bukowski

PMID: 12583824
DOI: 10.1007/s11912-003-0094-7

No abstract available

PubMed Disclaimer

Comment on

Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II study.
Bukowski R, Ernstoff MS, Gore ME, Nemunaitis JJ, Amato R, Gupta SK, Tendler CL. Bukowski R, et al. J Clin Oncol. 2002 Sep 15;20(18):3841-9. doi: 10.1200/JCO.2002.02.051. J Clin Oncol. 2002. PMID: 12228203 Clinical Trial.

References

1. Cancer. 2002 Jul 15;95(2):389-96 - PubMed
1. Blood. 2001 Sep 15;98 (6):1708-13 - PubMed
1. Cleve Clin J Med. 1997;64 Suppl 1:SI1-44; quiz SI45-7 - PubMed
1. J Clin Oncol. 1999 Aug;17(8):2530-40 - PubMed
1. Hepatology. 2001 Aug;34(2):395-403 - PubMed

Publication types

Actions